A shift of paradigm: from noradrenergic to dopaminergic modulation of learning?
d-Amphetamine coupled with behavioral training has been effective for improving functional recovery after stroke. d-amphetamine acts on multiple brain transmitter systems, but the recovery enhancing effect has been attributed to its noradrenergic actions. Another potent modulator of learning is dopamine, which may also enhance stroke recovery in humans. Based on data from previous studies of our group, we compared the learning enhancing effects of d-amphetamine with a more selective dopaminergic substance (levodopa) in identical protocols. Using a prospective, randomized, double-blind, placebo-controlled design, we had taught 60 male healthy subjects a miniature lexicon of 50 concrete nouns over the course of five consecutive training days using an associative learning principle. Subjects had received either d-amphetamine (0.25 mg/kg), levodopa/carbidopa (fixed dose of 100/25 mg), or placebo 90 min prior to training on each of the 5 days. Novel word learning was significantly enhanced in both the d-amphetamine and levodopa groups as compared to the placebo group. The learning superiority was maintained at the two re-assessments (1 week and 1 month post training). Both d-amphetamine and levodopa are thus potent drugs in enhancing learning in humans. We here discuss why the efficiency of both d-amphetamine and levodopa may be related to dopaminergic rather than noradrenergic actions.
Breitenstein
Caterina
C
Department of Neurology, University of Muenster, Germany; IZKF Münster, University of Muenster, Germany. breteins@uni-muenster.de
Flöel
Agnes
A
Korsukewitz
Catharina
C
Wailke
Stefanie
S
Bushuven
Stefan
S
Knecht
Stefan
S
D018663:Adrenergic Agents / Q000494:pharmacology; D000328:Adult; D000704:Analysis of Variance; D003913:Dextroamphetamine / Q000494:pharmacology; D004298:Dopamine / Q000502:physiology*; D015259:Dopamine Agents / Q000494:pharmacology; D004311:Double-Blind Method; D006801:Humans; D007858:Learning / Q000187:drug effects / Q000502:physiology*; D007980:Levodopa / Q000494:pharmacology; D008297:Male; D009483:Neuropsychological Tests; D009638:Norepinephrine / Q000502:physiology*; D013997:Time Factors
D018663:Adrenergic Agents; D015259:Dopamine Agents; D007980:Levodopa; D003913:Dextroamphetamine; D004298:Dopamine; D009638:Norepinephrine